Adaptive Symptom Care Using Fish-Based Nutritional Directives Post Breast Cancer
NCT04293874 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98
Last updated 2025-09-09
Summary
Inflammation has been consistently associated with psychoneurological symptoms (PNS) among breast cancer survivors (BCS). Evidence supporting interventional strategies promoting symptom-self management in reducing inflammation-induced PNS in BCS is limited. Current guidelines for BCS encourage the consumption of foods rich in omega-3 fatty acids. The omega-3 fatty acid docosahexaenoic acid (DHA), abundantly available in fish, has a role in inflammatory downregulation. Low dietary DHA has been associated with inflammation and fatigue in BCS. Dietary planning targeting increased fish consumption thereby reducing red and processed meats are components of the major nutritional recommendations for BCS. A critical gap exists in knowledge regarding interventions promoting adherence to dietary guidelines in BCS supporting PNS self-management. This investigation uses personalized meal planning among BCSs (n=150) who are 1-2 years post-treatment for early-stage breast cancer and experiencing PNS (pain, fatigue, depression, sleep disturbance, stress) to evaluate the feasibility of a personalized meal planning approach in supporting adherence to current dietary guidelines for BCS. As a first step in this program of research, we will evaluate the feasibility of an personalized meal planning approach in promoting adherence to dietary guidelines for BCS through evaluating the feasibility of a personalized meal planning approach in a cohort of BCSs with respect to recruitment, group allocation, salivary inflammatory quantification and receptivity to and adherence with dietary interventions. This investigation will also contribute to a preliminarily evaluation of the efficacy of high or low fish diet in reducing inflammation (IL-1β, IL-6, TNF-a) and PNS symptoms. Nationally, there is a priority for the development of personalized health strategies supporting self-management of adverse symptoms. This investigation focused on PNS in BCS is an initial step in generating new knowledge in efficacious approaches toward guiding decisions on dietary behavior change strategies that are personalized, cost-effective, and sustainable.
Conditions
- Fatigue
- Depression
- Pain
- Sleep Disturbance
- Stress
- Survivorship
- Breast Cancer
- Dietary Habits
Interventions
- BEHAVIORAL
-
Personalized Meal Plan
Personalized dietary plans will be developed incorporating the NPAGCS, while personalizing the plan based upon anthropometric characteristics, gender, age and self-reported activity level upon entry into the investigation, goals, typical dietary consumption patterns, and food preferences. A trained research assistant will use the USDA MyPlate88 site (www.choosemyplate.gov) to enter participant characteristics and determine the appropriate calorie level. A daily checklist will be then generated outlining the number of daily servings that should be consumed for each food group. Information will also be provided regarding serving sizes for different foods in the respective food groups and education will be provided regarding tailoring personal dietary preferences to meet the guidelines. Participants will be provided with a printed copy of their meal plan and instructed to initiate it for a 8-week period.
- BEHAVIORAL
-
Dietary Omega-3LC intervention
Following randomization, participants will be provided with fish to be consumed for 6 weeks. As a component of the dietary intervention, participants in high and low omega-3LC group will be provided with frozen, wild caught salmon (or if they dislike salmon, prepackaged, individual use foil packs of chunk light tuna). Salmon and chunk light tuna were chosen due to high omega-3LC content, low methylmercury content, low cost and ease of use. Vacuum packed, frozen salmon will be delivered to participants in large freezer bags and instructed to arrange visit times to ensure they can go directly home following the visit. Instructions for safe storage, fish handling and recipes to avoid fatigue of fish will be also be provided to participants when they receive the fish.
Sponsors & Collaborators
-
Hartford HealthCare
collaborator OTHER -
Seafood Industry Research Fund
collaborator UNKNOWN -
Alaskan Seafood Marketing Institute
collaborator UNKNOWN -
Academy of Nutrition and Dietetics
collaborator OTHER -
University of Connecticut
lead OTHER
Principal Investigators
-
Michelle P Judge, PhD · University of Connecticut
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 35 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-11
- Primary Completion
- 2020-11-01
- Completion
- 2020-11-01
Countries
- United States
Study Locations
More Related Trials
-
Omega 3 for Treatment of Depression in Patients With Heart Failure
NCT02057406 ·Status: COMPLETED ·Phase: PHASE3
-
A Prophylactic Trial of Omega-3 Polyunsaturated Fatty Acids in Bipolar Disorder
NCT04210804 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Omega-3 Phospholipids on Perceptual-cognitive Training
NCT01856829 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major Depression
NCT00361374 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Omega-3 Fatty Acids on Sleep and Behavior (Pilot Study)
NCT03694314 ·Status: COMPLETED ·Phase: NA
-
Omega-3 and Blueberry Supplementation in Age-Related Cognitive Decline
NCT01746303 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids and Exercise on Mobility and Cognition in Older Women
NCT03228550 ·Status: COMPLETED ·Phase: PHASE2
-
Polyunsaturated Fatty Acids (PUFA) Status and Cognitive Function in Healthy Young Adults
NCT01075958 ·Status: COMPLETED
-
The Effect of Omega-3 Polyunsaturated Fatty Acids in the Treatment and Prevention of Relapse of Bipolar Disorder
NCT01371383 ·Status: COMPLETED ·Phase: NA
-
26 Weeks' Dietary Supplementation With DHA- and EPA-enriched Oils on Sleep Efficiency in Healthy Adults
NCT03559361 ·Status: COMPLETED ·Phase: NA
-
Omega 3 FA Supplements as Augmentation in the Treatment of Depression
NCT01803711 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Comparison of Krill and Fish Oil on Clinical and Biochemical Outcomes in Depression
NCT06414226 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids for Major Depressive Disorder During Pregnancy
NCT00618865 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids in Adolescent Depression
NCT00312897 ·Status: COMPLETED ·Phase: PHASE2
-
Fish Oil (Omega 3), Immune Function, and Mood
NCT00385723 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Long-Chain Polyunsaturated Fatty Acids on Cognitive Performance and Mood
NCT00615277 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Unsaturated Fatty Acid Improves Cognitive Function in Patients With Depression
NCT04803071 ·Status: UNKNOWN ·Phase: NA
-
Effects of Omega-3 Fatty Acids Supplementation on Brain and Behaviour in Healthy Children.
NCT02346773 ·Status: COMPLETED ·Phase: NA
-
The Effects of DHA- and EPA-enriched Oils on Cognitive Function and Mood
NCT02763514 ·Status: COMPLETED ·Phase: NA
-
Effect of Polyunsaturated Fatty Acids on Cardiovascular and Motor Responses Under Stress
NCT00014027 ·Status: COMPLETED ·Phase: PHASE1
-
Omega-3 Polyunsaturated Fatty Acids on Major Depressive Disorder in Patients With Cardiovascular Diseases
NCT03072823 ·Status: COMPLETED ·Phase: NA
-
Effect of Omega-3 Supplementation During Pregnancy on Regulation of Stress
NCT01158976 ·Status: COMPLETED ·Phase: NA
-
Academic Stress and Proinflammatory Cytokines: Omega-3 Intervention
NCT00519779 ·Status: COMPLETED ·Phase: PHASE2
-
Synergistic Activity of Human Milk Nutrients and Infant Cognition
NCT03838536 ·Status: RECRUITING ·Phase: NA
-
Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation
NCT00167310 ·Status: COMPLETED ·Phase: PHASE2